UBS Cuts Shanghai Petrochemical Target After RMB1.4B Loss

Edgen Stock·Mar 20 2026, 03:50

Share to

Share to

Copy link

Key Takeaways

Shanghai Petrochemical's financial performance deteriorated significantly in 2025, driven by a sharp decline in refining margins and operational setbacks in the fourth quarter. While investment bank UBS trimmed its price target in response to the weak results, it maintained a "Buy" rating, suggesting a belief in the company's long-term value despite near-term headwinds.

Full-Year Loss: The company posted a net loss of RMB1.4 billion for 2025, a stark reversal from previous profitability, as revenue declined 13% year-over-year to RMB75.6 billion.
Q4 Margin Collapse: The fourth quarter was particularly challenging, contributing a RMB1 billion net loss as the company's gross margin fell to 12% from 17% in the prior quarter.
Analyst Revision: UBS lowered its price target on Shanghai Petrochemical's stock (00338.HK) to HKD2.02 from HKD2.11, reflecting the poor results, but kept its "Buy" rating intact.

Q4 Loss Reaches RMB1 Billion as Margins Weaken

Shanghai Petrochemical (00338.HK) reported a net loss of RMB1.4 billion for the 2025 fiscal year, confirming a previous profit warning. The loss came as annual revenue fell 13% year-over-year to RMB75.6 billion, signaling significant market and operational pressures.

The final quarter of the year accounted for the bulk of the financial damage. The company's net loss in Q4 2025 alone reached RMB1 billion. This sharp decline was primarily caused by a collapse in profitability, with gross margins contracting to 12% from 17% in the third quarter. The company attributed the poor performance to pressure on refining fundamentals and reduced product shipment volumes resulting from equipment maintenance.

UBS Trims Price Target to HKD2.02 But Maintains 'Buy' Rating

In response to the earnings report, UBS adjusted its outlook on Shanghai Petrochemical. The investment bank lowered its price target on the company's Hong Kong-listed shares to HKD2.02 from HKD2.11. This revision reflects the challenging fourth-quarter results and the difficult operating environment.

Despite the target price reduction and the company's substantial losses, UBS maintained its "Buy" rating. This decision suggests the bank may believe the negative factors are already priced into the stock or that a longer-term recovery is possible. For investors, this creates a nuanced picture of a company facing immediate profitability struggles but potentially retaining underlying value.